Serum IGF-1 in patients with rheumatoid arthritis: correlation with disease activity
- PMID: 35382860
- PMCID: PMC8981634
- DOI: 10.1186/s13104-022-06008-0
Serum IGF-1 in patients with rheumatoid arthritis: correlation with disease activity
Abstract
Objective: Insulin-like growth factor (IGF)-1 participates in modulating immunity and inflammation. Its bioactivity is controlled by six IGF-binding proteins (IGFBP-1 to IGFBP-6). In particular, the IGFBP-3 level is reportedly linked to the disease activity of rheumatoid arthritis (RA), consistent with our previous study. Therefore, the present study aimed to reproduce the previous results.
Results: The serum IGFBP-3 level was not significantly different among the three groups according to disease activity based on the DAS28-ESR/CRP (p > 0.05) but was significantly different between the low- and high-disease-activity groups based on the DAS28-CRP (p = 0.036). Meanwhile, the interleukin-6 (IL-6) level moderately correlated with DAS28-CRP (Spearman's rho = 0.583, p < 0.001).
Keywords: Disease activity; Insulin-like growth factor binding protein-3; Insulin-like growth factor-1; Rheumatoid arthritis.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous